Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo
Tian-ju Wan,1 Yi-Chuan Yu,1 Xiao-gang Zhao,1 Ping Tang,1 Yong-shu Gong2 1Department of Emergency, Yongchuan Hospital of Chongqing Medical University, Chongqing, China; 2Department of Pediatrics, Yongchuan Hospital of Chongqing Medical University, Chongqing, China Background: Some patients still co...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-11-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Subjects: | |
| Online Access: | https://www.dovepress.com/efficacy-of-betahistine-plus-cognitive-behavioral-therapy-on-residual--peer-reviewed-article-NDT |
| _version_ | 1818851433404956672 |
|---|---|
| author | Wan TJ Yu YC Zhao XG Tang P Gong YS |
| author_facet | Wan TJ Yu YC Zhao XG Tang P Gong YS |
| author_sort | Wan TJ |
| collection | DOAJ |
| description | Tian-ju Wan,1 Yi-Chuan Yu,1 Xiao-gang Zhao,1 Ping Tang,1 Yong-shu Gong2 1Department of Emergency, Yongchuan Hospital of Chongqing Medical University, Chongqing, China; 2Department of Pediatrics, Yongchuan Hospital of Chongqing Medical University, Chongqing, China Background: Some patients still complain of residual dizziness after successful canalith repositioning procedure (CRP) for benign paroxysmal positional vertigo (BPPV). Previous study found that compared to the low-dose betahistine, the high-dose betahistine could yield better efficacy in treating residual dizziness. Therefore, this study was conducted to assess whether the addition of cognitive behavioral therapy (CBT) could make low-dose betahistine produce similar results to high-dose betahistine in treating residual dizziness. Methods: The recruited patients were randomly assigned to receive either low-dose betahistine (6 mg/time, three times/day) or high-dose betahistine (12 mg/time, three times/day). Patients in the low-dose group also received CBT (twice a week, 1 hour per time). The treatment was continued for 4 weeks. The duration of residual dizziness, 25-item Dizziness Handicap Inventory (DHI), Hamilton Anxiety Rating Scale (HARS), and Hamilton Depression Rating Scale (HDRS) were recorded and analyzed. The duration of residual dizziness and DHI score were the primary outcomes, and the HARS and HDRS scores were the secondary outcomes. Results: Each group had 50 patients. After treatment, the average DHI scores, HDRS scores, and HARS scores were significantly decreased in both groups. The duration of residual dizziness and average DHI score were nonsignificantly different (P=0.08; P=0.06) between the two groups, although they were lower in the low-dose group. Compared to the high-dose group, the low-dose group had the significantly lower average HDRS score (P=0.007) and HARS score (P=0.02). Meanwhile, four patients in the high-dose group experienced intolerable stomach upset. Conclusion: These results demonstrated that the addition of CBT could make low-dose betahistine produce similar results to high-dose betahistine in treating residual dizziness. Moreover, the low-dose betahistine plus CBT showed some advantages over high-dose betahistine in relieving depressive and anxiety symptoms and should be further explored. Keywords: residual dizziness, benign paroxysmal positional vertigo, BPPV, cognitive behavioral therapy, CBT, betahistine |
| first_indexed | 2024-12-19T07:04:57Z |
| format | Article |
| id | doaj.art-9ca229b9482d4d77a7a496991cbb34ba |
| institution | Directory Open Access Journal |
| issn | 1178-2021 |
| language | English |
| last_indexed | 2024-12-19T07:04:57Z |
| publishDate | 2018-11-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Neuropsychiatric Disease and Treatment |
| spelling | doaj.art-9ca229b9482d4d77a7a496991cbb34ba2022-12-21T20:31:19ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212018-11-01Volume 142965297142064Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigoWan TJYu YCZhao XGTang PGong YSTian-ju Wan,1 Yi-Chuan Yu,1 Xiao-gang Zhao,1 Ping Tang,1 Yong-shu Gong2 1Department of Emergency, Yongchuan Hospital of Chongqing Medical University, Chongqing, China; 2Department of Pediatrics, Yongchuan Hospital of Chongqing Medical University, Chongqing, China Background: Some patients still complain of residual dizziness after successful canalith repositioning procedure (CRP) for benign paroxysmal positional vertigo (BPPV). Previous study found that compared to the low-dose betahistine, the high-dose betahistine could yield better efficacy in treating residual dizziness. Therefore, this study was conducted to assess whether the addition of cognitive behavioral therapy (CBT) could make low-dose betahistine produce similar results to high-dose betahistine in treating residual dizziness. Methods: The recruited patients were randomly assigned to receive either low-dose betahistine (6 mg/time, three times/day) or high-dose betahistine (12 mg/time, three times/day). Patients in the low-dose group also received CBT (twice a week, 1 hour per time). The treatment was continued for 4 weeks. The duration of residual dizziness, 25-item Dizziness Handicap Inventory (DHI), Hamilton Anxiety Rating Scale (HARS), and Hamilton Depression Rating Scale (HDRS) were recorded and analyzed. The duration of residual dizziness and DHI score were the primary outcomes, and the HARS and HDRS scores were the secondary outcomes. Results: Each group had 50 patients. After treatment, the average DHI scores, HDRS scores, and HARS scores were significantly decreased in both groups. The duration of residual dizziness and average DHI score were nonsignificantly different (P=0.08; P=0.06) between the two groups, although they were lower in the low-dose group. Compared to the high-dose group, the low-dose group had the significantly lower average HDRS score (P=0.007) and HARS score (P=0.02). Meanwhile, four patients in the high-dose group experienced intolerable stomach upset. Conclusion: These results demonstrated that the addition of CBT could make low-dose betahistine produce similar results to high-dose betahistine in treating residual dizziness. Moreover, the low-dose betahistine plus CBT showed some advantages over high-dose betahistine in relieving depressive and anxiety symptoms and should be further explored. Keywords: residual dizziness, benign paroxysmal positional vertigo, BPPV, cognitive behavioral therapy, CBT, betahistinehttps://www.dovepress.com/efficacy-of-betahistine-plus-cognitive-behavioral-therapy-on-residual--peer-reviewed-article-NDTresidual dizzinessbenign paroxysmal positional vertigoBPPVcognitive behavior therapyCBTbetahistine |
| spellingShingle | Wan TJ Yu YC Zhao XG Tang P Gong YS Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo Neuropsychiatric Disease and Treatment residual dizziness benign paroxysmal positional vertigo BPPV cognitive behavior therapy CBT betahistine |
| title | Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo |
| title_full | Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo |
| title_fullStr | Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo |
| title_full_unstemmed | Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo |
| title_short | Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo |
| title_sort | efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo |
| topic | residual dizziness benign paroxysmal positional vertigo BPPV cognitive behavior therapy CBT betahistine |
| url | https://www.dovepress.com/efficacy-of-betahistine-plus-cognitive-behavioral-therapy-on-residual--peer-reviewed-article-NDT |
| work_keys_str_mv | AT wantj efficacyofbetahistinepluscognitivebehavioraltherapyonresidualdizzinessaftersuccessfulcanalithrepositioningprocedureforbenignparoxysmalpositionalvertigo AT yuyc efficacyofbetahistinepluscognitivebehavioraltherapyonresidualdizzinessaftersuccessfulcanalithrepositioningprocedureforbenignparoxysmalpositionalvertigo AT zhaoxg efficacyofbetahistinepluscognitivebehavioraltherapyonresidualdizzinessaftersuccessfulcanalithrepositioningprocedureforbenignparoxysmalpositionalvertigo AT tangp efficacyofbetahistinepluscognitivebehavioraltherapyonresidualdizzinessaftersuccessfulcanalithrepositioningprocedureforbenignparoxysmalpositionalvertigo AT gongys efficacyofbetahistinepluscognitivebehavioraltherapyonresidualdizzinessaftersuccessfulcanalithrepositioningprocedureforbenignparoxysmalpositionalvertigo |